Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer

ABSTRACT: Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer

PROVIDER: PRJNA115897 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2009-10-06 | GSE15460 | GEO

Oncogenic pathway combinations predict clinical prognosis in gastric cancer.

Project description:Many solid cancers are known to exhibit a high degree of heterogeneity in their deregulation of different oncogenic pathways. We sought to identify major oncogenic pathways in gastric cancer (GC) with significant relationships to patient survival. Using gene expression signatures, we devised an in silico strategy to map patterns of oncogenic pathway activation in 301 primary gastric cancers, the second highest cause of global cancer mortality. We identified three oncogenic pathways (proliferation/stem cell, NF-kappaB, and Wnt/beta-catenin) deregulated in the majority (>70%) of gastric cancers. We functionally validated these pathway predictions in a panel of gastric cancer cell lines. Patient stratification by oncogenic pathway combinations showed reproducible and significant survival differences in multiple cohorts, suggesting that pathway interactions may play an important role in influencing disease behavior. Individual GCs can be successfully taxonomized by oncogenic pathway activity into biologically and clinically relevant subgroups. Predicting pathway activity by expression signatures thus permits the study of multiple cancer-related pathways interacting simultaneously in primary cancers, at a scale not currently achievable by other platforms.

| S-EPMC2748685 | biostudies-literature

Emergent gene expression responses to drug combinations predict higher-order drug interactions

Project description:Effective design of combination therapies requires understanding the changes in cell physiology resulting from drug interactions. Here, we show that the genome-wide transcriptional response to combinations of two drugs, measured at a rigorously controlled growth rate, can predict higher-order antagonism with a third drug in Saccharomyces cerevisiae. Using isogrowth profiling, over 90% of the variation in cellular response can be decomposed into three principal components (PCs) that have clear biological interpretations. We demonstrate that the third PC captures emergent transcriptional programs that are dependent on both drugs and can predict antagonism with a third drug targeting the emergent pathway. We further show that emergent gene expression patterns are most pronounced at a drug ratio where the drug interaction is strongest, providing a guideline for future measurements. Our results provide a readily applicable recipe for uncovering emergent responses in other systems and for higher-order drug combinations.

2019-10-02 | GSE138256 | GEO

CircRNA expression-profiling to predict prognosis in locoregionally advanced nasopharyngeal carcinoma

Project description:CircRNA expression-profiling to predict prognosis in locoregionally advanced nasopharyngeal carcinoma

| PRJNA786569 | ENA

Transcription profiling of human CLL - a genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia - super series

Project description:This SuperSeries is composed of the following subset Series:; GSE10137: A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia (Mayo_Ohio); GSE10138: A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia (Duke_VA) Experiment Overall Design: Refer to individual Series

2009-11-09 | E-GEOD-10139 | biostudies-arrayexpress

Modeling the next-generation of rhabdomyosarcoma organoids to predict effective drug combinations

Project description:Modeling the next-generation of rhabdomyosarcoma organoids to predict effective drug combinations

| PRJNA1041875 | ENA

Emergent gene expression responses to drug combinations predict higher-order drug interactions

Project description:Emergent gene expression responses to drug combinations predict higher-order drug interactions

| PRJNA575231 | ENA

Modeling the next-generation of rhabdomyosarcoma organoids to predict effective drug combinations [RNAseq]

Project description:Modeling the next-generation of rhabdomyosarcoma organoids to predict effective drug combinations [RNAseq]

| PRJNA1041880 | ENA

Modeling the next-generation of rhabdomyosarcoma organoids to predict effective drug combinations [methylation]

Project description:Modeling the next-generation of rhabdomyosarcoma organoids to predict effective drug combinations [methylation]

| PRJNA1041882 | ENA

Modeling the next-generation of rhabdomyosarcoma organoids to predict effective drug combinations [scRNAseq]

Project description:Modeling the next-generation of rhabdomyosarcoma organoids to predict effective drug combinations [scRNAseq]

| PRJNA1041883 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data